A locking top for blocking a stopper in the neck of a vessel comprises an outer body and a cage that is configured to fit into and lock axially in the outer body. The cage comprises an upper ring, a plurality n of branches connected to the upper ring, n/2 median bridges and n/2 lower bridges arranged in alternation on the periphery of the cage, each connecting together two adjacent branches. When the top is in an intermediate holding position in which the stopper is partially pushed into the neck, the lower bridges surround, at least in part, a collar of the neck; the median bridges located, in an axial direction, between the upper ring and the lower bridges are designed to form an open space between them and the collar.

A product packaging container for containing and displaying a product. The container includes a lid and a container portion. The lid has a lid rim and lid outer side having a semi-spherical lid outer surface. The lid is formed of a translucent material and the lid is optically magnifying with respect to light passing through the lid. The container portion having a container portion inner side and defining a container longitudinal axis. The container portion inner side being defined by a container portion rim. The container portion has a product cavity. The lid is only able to move along the longitudinal axis from an engaged configuration to a separated configuration upon the lid being rotationally aligned with the container portion at a predetermined position about the longitudinal axis, and the container portion being flexed in plastic deformation in response to a lateral compressive force radially inward toward the longitudinal axis.

Provided is a system and method for multi-modal dosing of a product. The system provides a control base for coupling to one of a plurality of different cartridges containing product, at least two cartridges having different modalities of deliverythe coupled control base and selected cartridge providing a dosing device. Each cartridge has at least a unique identifier, which may be read by the control base and correlated through a database to confirm that the user is authorized to use the cartridge, and use of the cartridge for a dose of product will not conflict with other products received by the user and known to the system. Cartridges that are not coupled to the control base are non-functional and cannot dispense product as intended with the system. An associated method of use is also provided.

Provided is a system and method for multi-modal dosing of a product. The system provides a control base for coupling to one of a plurality of different cartridges containing product, at least two cartridges having different modalities of deliverythe coupled control base and selected cartridge providing a dosing device. Each cartridge has at least a unique identifier, which may be read by the control base and correlated through a database to confirm that the user is authorized to use the cartridge, and use of the cartridge for a dose of product will not conflict with other products received by the user and known to the system. Cartridges that are not coupled to the control base are non-functional and cannot dispense product as intended with the system. An associated method of use is also provided.

A device is described for facilitating the preparation of therapeutic foam e.g. for the treatment of varicose veins. A pressurised vial contains a sclerosant liquid, e.g., polidocanol solution, and a sterile gas which is readily absorbed by the body, e.g., carbon dioxide, oxygen or a mixture of these gases. The vial is provided either with a specialised stopper/seal into which a syringe nozzle may be inserted or alternatively a septum seal which may be penetrated by a hypodermic needle. The quantities of gas and liquid and the pressure in the vial are pre-set so that, on connection of a syringe to the vial, a predetermined volume of both gas and liquid is transferred to the syringe, with the intention that the syringe is then used to make a foam by known means. The use of the vial ensures that the ratio of gas to liquid in the foam is standardised, and also provides a convenient way of packaging the gas and liquid and of filling the syringe in a sterile manner.

This disclosure relates generally to a smart closure for any container that has lock/unlock features, and can be accessed using keypad or biometrics, also including RFID, Bluetooth, or wireless control and communication. This can also include monitoring solutions, with data logging. For example, time of access, temperature, weight, or other environmental conditions. The closure and container assembly present a positive lock mechanism designed to provide an affirmative indication that full closure has been attained.

A universal pill bottle cap for securely locking up medications with a high-risk factor for abuse and theft. The pill bottle cap includes a unique locking mechanism, a biometric scanning locking mechanism, a one-step opening process, and a universal applicability. The unique locking mechanism includes a sliding latch on the underside of the cap that will allow a pill bottle to be inserted and the cap to lock around the pill bottle until an authorized user follows a prompt to unlock the cap from the bottle. The biometric scanner opens either the sliding mechanism to allow the pill bottle to be removed or opens the lid to allow access to the contents of the bottle. This depends on a button on the underside of the pill bottle cap. The pill bottle has a microprocessor that drives the functionality of the cap.

A monitoring system includes a weight sensor for receiving a vial containing a controlled substance possessed by a patient. A processor receives a weight measured by the weight sensor. A communication circuit transmits the weight measured by the weight sensor to a remote server. The weight sensor may be mounted in a container having a first compartment and a second compartment. The first compartment has a first lid that is releasable without any lock. A second compartment has a second lid that is secured by a lock. The weight sensor is mounted inside the second compartment.

The present discloser provides methods and systems related to a medication container that may be locked using a locking mechanism. In one exemplary method, a request from a user may be received by a medication provider for a medication. The medication may be placed in a medication container with a locking mechanism that is operable to lock and unlock the medication container. The medication container may be locked using the locking mechanism. The locked medication container with the medication within may be provided to the user. Subsequent to providing the locked medication container to the user, a request may be received from the user to access the medication in the medication container. A credential may be sent to the user that is usable, via the locking mechanism, to unlock the medication container. The user may then input the credential into the locking mechanism to unlock the medication container and access the medication therein.

The present discloser provides methods and systems related to a medication container that may be locked using a locking mechanism. In one exemplary method, a request from a user may be received by a medication provider for a medication. The medication may be placed in a medication container with a locking mechanism that is operable to lock and unlock the medication container. The medication container may be locked using the locking mechanism. The locked medication container with the medication within may be provided to the user. Subsequent to providing the locked medication container to the user, a request may be received from the user to access the medication in the medication container. A credential may be sent to the user that is usable, via the locking mechanism, to unlock the medication container. The user may then input the credential into the locking mechanism to unlock the medication container and access the medication therein.